IFP Advisors’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.57K Sell
96
-68
-41% -$1.28K ﹤0.01% 4332
2026
Q2
$2.48K Buy
164
+95
+138% +$1.66K ﹤0.01% 4142
2026
Q1
$1.32K Hold
69
– – ﹤0.01% 4106
2025
Q4
$1.52K Buy
69
+4
+6% +$72 ﹤0.01% 3933
2025
Q3
$789 Buy
+65
New +$880 ﹤0.01% 4028
2025
Q2
– Sell
-96
Closed -$1.9K – 3428
2025
Q1
$1.84K Buy
96
+1
+1% +$29 ﹤0.01% 3168
2024
Q4
$3.49K Sell
95
-1
-1% -$34 ﹤0.01% 2921
2024
Q3
$4.07K Hold
96
– – ﹤0.01% 2729
2024
Q2
$3.87K Hold
96
– – ﹤0.01% 2645
2024
Q1
$3.4K Hold
96
– – ﹤0.01% 2562
2023
Q4
$2.84K Sell
96
-145
-60% -$3.01K ﹤0.01% 2585
2023
Q3
$5.01K Hold
241
– – ﹤0.01% 2501
2023
Q2
$5.91K Sell
241
-26
-10% -$836 ﹤0.01% 2494
2023
Q1
$3.85K Sell
267
-98
-27% -$4.06K ﹤0.01% 2674
2022
Q4
$7K Sell
365
-8
-2% -$362 ﹤0.01% 3632
2022
Q3
$11K Sell
373
-25
-6% -$1.37K ﹤0.01% 3600
2022
Q2
$11K Hold
398
– – ﹤0.01% 3355
2022
Q1
$11K Buy
398
+37
+10% +$4.32K ﹤0.01% 3352
2021
Q4
$54K Hold
361
– – ﹤0.01% 1522
2021
Q3
$43K Sell
361
-200
-36% -$22K ﹤0.01% 1646
2021
Q2
$55K Hold
561
– – ﹤0.01% 1486
2021
Q1
$50K Buy
+561
New +$52.1K ﹤0.01% 1472
2020
Q3
– Sell
-1,760
Closed -$185K – 3006
2020
Q2
$153K Buy
+1,760
New +$140K 0.01% 765
2019
Q1
$10K Sell
150
-1,607
-91% -$84.4K ﹤0.01% 1620
2018
Q4
$66K Buy
1,757
+772
+78% +$27.3K ﹤0.01% 1439
2018
Q3
$42K Buy
985
+250
+34% +$8.73K ﹤0.01% 1992
2018
Q2
$16K Buy
+735
New +$9.04K ﹤0.01% 2614
2016
Q2
– Sell
-15
Closed -$10K – 4070
2016
Q1
$10K Sell
15
-59
-80% -$5.16K ﹤0.01% 1621
2015
Q4
$9K Buy
+74
New +$7.34K ﹤0.01% 2647

Other funds holding TNDM

IFP Advisors's TNDM Position: Q3 2026 in Review

IFP Advisors reduced its Tandem Diabetes Care (TNDM) stake by 41% in Q3 2026, selling an estimated $1.28K and leaving 96 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #4332.

IFP Advisors first reported a position in TNDM in Q4 2015 and has held it in 29 quarters since. The position peaked at $153K in Q2 2020. 87 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • IFP Advisors held 96 shares of Tandem Diabetes Care worth $1.57K as of Q3 2026.
  • IFP Advisors sold 68 Tandem Diabetes Care shares in Q3 2026, an estimated $1.28K.
  • Tandem Diabetes Care made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4332 holding.
  • IFP Advisors first reported a position in Tandem Diabetes Care in Q4 2015 and has held it in 29 quarters since.
  • IFP Advisors's Tandem Diabetes Care position peaked at $153K in Q2 2020.
  • 87 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.